Jenna A. Milstein

Jenna A. Milstein

Auto-generated profile, based on publicly available information

Jenna A. Milstein

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2020 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
YYYang Yang
Yang Yang
LDLeon J. Delalio
Leon J. Delalio
ABAngela K. Best
Angela K. Best
EMEdgar Macal
Edgar Macal
JMJenna Milstein
Jenna Milstein
Scott Robert JohnstoneScott Robert Johnstone
Scott Robert Johnstone
The proinflammatory cytokine IL-1β is a significant risk factor in cardiovascular disease that can be targeted to reduce major cardiovascular events. IL-1β expression and release are tightly controlled by changes in intracellular Ca2+ ([Ca2+]i), which has been associated with ATP release and purinergic signaling. Despite this, the mechanisms that regulate these changes have not been identified. The pannexin 1 (Panx1) channels have canonically been implicated in ATP release, especially during inflammation. We examined Panx1 in human umbilical vein endothelial cells following treatment with the proinflammatory cytokine TNF-α. Analysis by whole transcriptome sequencing and immunoblot identified a dramatic increase in Panx1 mRNA and protein expression that is regulated in an NF-κB–dependent manner. Furthermore, genetic inhibition of Panx1 reduced the expression and release of IL-1β. We initially hypothesized that increased Panx1-mediated ATP release acted in a paracrine fashion to control cytokine expression. However, our data demonstrate that IL-1β expression was not altered after direct ATP stimulation in human umbilical vein endothelial cells. Because Panx1 forms a large pore channel, we hypothesized it may permit Ca2+ diffusion into the cell to regulate IL-1β. High-throughput flow cytometric analysis demonstrated that TNF-α treatments lead to elevated [Ca2+]i, corresponding with Panx1 membrane localization. Genetic or pharmacological inhibition of Panx1 reduced TNF-α–associated increases in [Ca2+]i, blocked phosphorylation of the NF-κB–p65 protein, and reduced IL-1β transcription. Taken together, the data in our study provide the first evidence, to our knowledge, that [Ca2+]i regulation via the Panx1 channel induces a feed-forward effect on NF-κB to regulate IL-1β synthesis and release in endothelium during inflammation.

28 August 2025 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
DSDanish Iltaf Satti
Danish Iltaf Satti
JCJeffrey Shi Kai Chan
Jeffrey Shi Kai Chan
RWRobert Weinstein
Robert Weinstein
JPJulia De Conti Pelanda
Julia De Conti Pelanda
HMHassan Mirbolouk
Hassan Mirbolouk
DSDavid Spragg
David Spragg

1 May 2023 in JACC: Case Reports
Verified
Journal Article
Open access
JMJenna A. Milstein
Jenna A. Milstein
DBDominik Beer
Dominik Beer
JTJohn Thomson
John Thomson
ACAri Cedars
Ari Cedars
KKKlitos Konstantinidis
Klitos Konstantinidis
Atrial fibrillation (AF) is common in adults with unrepaired atrial septal defects (ASDs). Sinus venosus (SV) ASDs associated with partial anomalous pulmonary venous return (PAPVR) are traditionally managed surgically. We report the first AF catheter ablation in a patient with SV ASD and PAPVR preceding transcatheter ASD repair with a covered stent. (Level of Difficulty: Advanced.)

19 February 2025 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
SLSteven Liskov
Steven Liskov
JMJenna A. Milstein
Jenna A. Milstein
ABAndreas S. Barth
Andreas S. Barth
ACAri Cedars
Ari Cedars
BMBret A. Mettler
Bret A. Mettler
Konstantinos N AronisKonstantinos N Aronis
Konstantinos N Aronis